RE:Quick poll
I think an expedited approval in whatever form is almost a foregone conclusion based on the optimized data trends...I'm not too concerned about the "if" & I never like to predict the "when" in this business, but I'd certainly consider an approval to be a "near-term" event when viewed in the context of the number of years most here have been invested.
The better question imo is what is the best path moving forward to expedite adoption of our ACT? As I've stated in the past, I'm hoping an influencer in the field (I.e. physician(s) &/or influential treatment center/academic institution) can carry the torch for TLT. An important pre-commercialization step for a promising tech is making those important connections with not only Pharma, but with physician leaders & major centers that make up an integral part of establishing SOC/new treatment guidelines to be adopted. We all want a quick ROI, but we also need to stay patient & keep in mind there are a lot of moving parts. The more these parts work together/in parallel, the earlier the commercial success...this is when true value is created. I'm staying patient until that fruition. Good luck...